These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2142969)

  • 1. New aspects for the therapy of Crohn's disease.
    Rohr G; Usadel KH
    Klin Wochenschr; 1990; 68 Suppl 21():64-8. PubMed ID: 2142969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.
    James SP; Neckers LM; Graeff AS; Cossman J; Balch CM; Strober W
    Gastroenterology; 1984 Jun; 86(6):1510-8. PubMed ID: 6232165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covert suppressor T cells in Crohn's disease.
    Elson CO; Graeff AS; James SP; Strober W
    Gastroenterology; 1981 Jun; 80(6):1513-21. PubMed ID: 6453036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy of Crohn's disease.
    van Montfrans C; Camoglio L; van Deventer SJ
    Mediators Inflamm; 1998; 7(3):149-52. PubMed ID: 9705600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
    Auer IO; Röder A; Fröhlich J
    Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of Crohn's disease using Colibiogen. Cellular reactions of the immune system in patients with Crohn's disease].
    Auer IO; Röder A; Mittelstaedt A
    Fortschr Med; 1985 Dec; 103(46):1076-80. PubMed ID: 2935464
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ulcerative colitis and Crohn disease from the immunologic viewpoint].
    Storch W
    Z Gesamte Inn Med; 1993 Feb; 48(2):49-51. PubMed ID: 8465545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
    Victorino RM
    J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
    Brand S
    Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypogammaglobulinemia due to abnormal suppressor T-cell activity in Crohn's disease.
    Elson CO; James SP; Graeff AS; Berendson RA; Strober W
    Gastroenterology; 1984 Mar; 86(3):569-76. PubMed ID: 6229445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current status of T-lymphocyte apheresis (TLA) treatment of Crohn's disease.
    Bicks RO; Groshart KD
    J Clin Gastroenterol; 1989 Apr; 11(2):136-8. PubMed ID: 2786898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel strategies to attenuate immune activation in Crohn's disease.
    Bamias G; Cominelli F
    Curr Opin Pharmacol; 2006 Aug; 6(4):401-7. PubMed ID: 16753341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease.
    Hibi T; Inoue N; Ogata H; Naganuma M
    J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional suppressor T cell activity in Crohn's disease and the effects of sulphasalazine.
    Holdstock G; Chastenay BF; Krawitt EL
    Clin Exp Immunol; 1982 Jun; 48(3):619-24. PubMed ID: 6126286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T-lymphocyte subpopulations in the peripheral blood of patients with Crohn disease].
    Purrmann J; Hengels KJ; Cleveland S; Gemsa R; Koldehoff M; Strohmeyer G
    Z Gastroenterol; 1990 May; 28(5):242-6. PubMed ID: 2144933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gene therapy with interleukin 10 in Crohn's disease: too early yet].
    Dijkstra G; Hospers GA; Kleibeuker JH
    Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2153-6. PubMed ID: 14626830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell immunoregulation in patients with inflammatory bowel disease. II. Enhanced suppressor T-cell activity in ulcerative colitis.
    Kramer JK; Depew WT; Szewczuk MR
    J Clin Lab Immunol; 1988 Jan; 25(1):19-27. PubMed ID: 2968458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular immune mechanisms in the pathogenesis of Crohn's disease.
    James SP
    In Vivo; 1988; 2(1):1-7. PubMed ID: 2979807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses.
    González MA; Gonzalez-Rey E; Rico L; Büscher D; Delgado M
    Gastroenterology; 2009 Mar; 136(3):978-89. PubMed ID: 19135996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to tumor necrosis factor-alpha in the treatment of Crohn's disease.
    Brown SJ; Abreu MT
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):160-8. PubMed ID: 15782540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.